"I am thoroughly satisfied with the publisher. Even during the pandemic we received regular updates on our submitted manuscript. The communication was very simple and the editors involved in the processing of our manuscript were prompt and helpful in any/all queries throughout the publication process."
Bhupesh Sharma (Department of Pharmacology, Amity Institute of Pharmacy, Amity University Uttar Pradesh, Noida, India)
"I am feeling happy to see my article in your journal. My experience of working with Bentham Science Publishers is excellent. Thank you so much."
"We are very satisfied by the services of Bentham Science Publishers; due to which we publish the majority of our papers with you."
Florin Borcan (Faculty of Pharmacy, “Victor Babes” University of Medicine and Pharmacy, Timisoara, Romania)
"I would like to express my satisfaction about my first experience of publishing an article in Current Enzyme Inhibition (Bentham). The manuscript was evaluated in a timely manner and the first proofs prepared quickly and to my satisfaction. I also appreciated the professional work of staff and I am very satisfied with the final result. Thank you and congratulations.
PhD. Prof. Donald Poirier (Quebec City, Canada)
Claudiu T. Supuran (83932 citations) Neurofarba Department University of Florence Florence (Italy) Biography
Biography of Claudiu T. Supuran
CLAUDIU T. SUPURAN is professor of medicinal chemistry at the Neurofarba Department, Section of Pharmaceutical and Nutriceutical Sciences, University of Florence, Italy. He has published more than 1250 papers, his Hirsch factor is h = 110; the number of citations since 1995 > 49800. His main research interest is on enzyme inhibitors, and especially carbonic anhydrase inhibitors, of which he discovered several new classes in the last years. One of the sulfonamides discovered in his group entered Phase I clinical trials in 2014 for the treatment of advanced, metastatic solid tumors. He is Editor-in-Chief of Expert Opinion on Therapeutic Patents, Journal of Enzyme Inhibition and Medicinal Chemistry, Current Enzyme Inhibition, etc. For the last 25 years the main interest of his research was focused on metallo-enzymes and their modulators of activity. In 2013 he was rated as the most cited scientists in Pharmacology & Toxicology by LabTimes (LabTimes 2013, 5, 38).